MICM
CBPO

Matthews International Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Matthews International Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,400
Closed -$3.82M – 47
2017
Q3 		$3.82M Buy
41,400
+10,300
+33% +$990K 0.16% 37
2017
Q2 		$3.52M Buy
31,100
+2,900
+10% +$324K 0.16% 33
2017
Q1 		$2.82M Buy
28,200
+3,900
+16% +$417K 0.14% 33
2016
Q4 		$2.61M Sell
24,300
-11,300
-32% -$1.32M 0.13% 29
2016
Q3 		$4.43M Buy
35,600
+2,100
+6% +$248K 0.18% 28
2016
Q2 		$3.56M Sell
33,500
-60,454
-64% -$7.02M 0.16% 27
2016
Q1 		$10.8M Sell
93,954
-12,400
-12% -$1.45M 0.48% 21
2015
Q4 		$15.2M Sell
106,354
-30,500
-22% -$3.52M 0.68% 16
2015
Q3 		$12.3M Sell
136,854
-46,600
-25% -$4.92M 0.55% 18
2015
Q2 		$21.1M Sell
183,454
-15,000
-8% -$1.58M 0.73% 15
2015
Q1 		$19M Buy
198,454
+44,600
+29% +$3.34M 0.66% 15
2014
Q4 		$10.3M Buy
+153,854
New +$9.53M 0.43% 22

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Matthews International Capital Management's CBPO Position: Q4 2017 in Review

Matthews International Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 41,400 shares — an estimated $3.82M sold.

Matthews International Capital Management first reported a position in CBPO in Q4 2014 and held it in 12 quarters. The position peaked at $21.1M in Q2 2015. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • Matthews International Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Matthews International Capital Management sold 41,400 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $3.82M.
  • Matthews International Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 12 quarters.
  • Matthews International Capital Management's China Biologic Products Holdings, Inc. position peaked at $21.1M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Matthews International Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.